Vulvovaginal candidiasis (VVC) is characterized as a
very common
fungal infection that significantly affects women’s health
worldwide. Essential oils (EOs) are currently being evaluated as an
alternative therapy. The development of efficient techniques such
as micro- or nanoencapsulation for protecting and controlling release
is essential to overcome the limitations of EO applications. Therefore,
the aim of this study was to develop and characterize oregano EO-loaded
keratin microparticles (OEO-KMPs) as a potential treatment for VVC.
OEO-KMPs were produced using high-intensity ultrasonic cycles and
characterized in terms of morphological and physicochemical parameters. In vitro evaluation included assessing the toxicity of the
OEO-KMPs and their effect against Candida albicans using microdilution and agar diffusion, while the activity against
biofilm was quantified using colony forming units (CFU). The efficacy
of the OEO-KMPs in an in vivo VVC mouse model was
also studied. Female BALB/c mice were intravaginally infected with C. albicans, 24 h postinfection animals were treated
intravaginally with 15 μL of OEO-KMPs and 24 h later vaginal
fluid was analyzed for C. albicans and Lactobacillus growth (CFU mL–1). The results
showed the stability of the OEO-KMPs over time, with high encapsulation
efficiency and controlled release. This nanoparticle size facilitated
penetration and completely inhibited the planktonic growth of C. albicans. In addition, an in vitro application of 2.5% of the OEO-KMPs eradicated mature C. albicans biofilms while preserving Lactobacillus species.
In in vivo, a single intravaginal application of
OEO-KMPs induced a reduction in C. albicans growth,
while maintaining Lactobacillus species. In conclusion,
this therapeutic approach with OEO-KMPs is promising as a potential
alternative or complementary therapy for VVC while preserving vaginal
microflora.